Malabsorption News

Among infants at-risk for celiac disease, delayed introduction of dietary gluten was associated with delayed onset of disease, according to new research data.

Asymptomatic individuals who tested positive for serologic markers of celiac disease benefited from a gluten-free diet, supporting active screening for the disease in at-risk groups, according to clinical trial results.

This month new FDA standards for the labeling of gluten-free food products went into effect, assuring people with celiac disease that “foods labeled ‘gluten-free’ meet a clear standard established and enforced by the FDA” for the first time in the US. In light of this improvement to the celiac treatment landscape, here are seven highlights of celiac disease research presented recently on Healio.com/Gastroenterology.

Serological testing of two specific celiac autoantibodies in children with celiac disease adhering to a gluten-free diet effectively identified mucosal recovery, according to new research data.

Celiac disease in pregnant women is not associated with a significantly greater risk for pregnancy complications or adverse birth outcomes, according to new research data.

Celiac disease patients do not have an increased risk for malignant cancers overall, but they do after 5 years from clinical diagnosis of celiac disease, according to new research data.

The FDA standards established in August 2013 defining requirements for food products labeled “gluten-free” go into effect today, according to an FDA consumer update.

Anthera Pharmaceuticals has acquired Sollpura from Eli Lilly and plans to license it to newly formed subsidiary Alkira Therapeutics for future development, according to a press release.

Children of parents with celiac disease had an increased but minor risk for congenital malformation, according to results from a nationwide study in Sweden.

Children with HLA haplotype DR3-DQ2, especially homozygotes with two copies, had high risk for celiac disease, and that risk was elevated in Sweden, according to data published in The New England Journal of Medicine.